Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06915792 · ClinicalTrials.gov registry record · Phase 4
PEACE Trial: Postpartum Evaluation of Antihypertensive Cessation and Efficacy
A Phase 4 study, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 110
- Enrollment target
NCT06915792 is a Phase 4 study that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 110 participants.
The verdict
NCT06915792, a Phase 4 study, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 110 participants
- Enrollment target
Study Summary
This randomized controlled trial compares two common medications, labetalol and extended-release nifedipine, to determine which is more effective at managing postpartum high blood pressure. We hypothesize that extended-release nifedipine will better control blood pressure and reduce the need for continued medication beyond six weeks postpartum. The study will enroll 110 postpartum participants, randomly assigning them to one of the two medications, with remote blood pressure monitoring to evaluate treatment effectiveness and inform postpartum hypertension management.
Interventions
- DRUG Labetalol
- DRUG Nifedipine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2025-06-01 |
| Est. Completion | 2027-10-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06915792
The ClinicalTrials.gov registry entry for NCT06915792 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Labetalol is the first listed.
NCT06915792 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06915792 about?
NCT06915792 is a clinical study titled "PEACE Trial: Postpartum Evaluation of Antihypertensive Cessation and Efficacy". This randomized controlled trial compares two common medications, labetalol and extended-release nifedipine, to determine which is more effective at managing postpartum high blood pressure. We hypothesize that extended-release nifedipine will better control blood pressure and reduce the need for con...
What is the current status of trial NCT06915792?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 110 participants. The study started on 2025-06-01. Estimated completion is 2027-10-31.
What interventions are being tested in trial NCT06915792?
The interventions under investigation include: Labetalol (DRUG), Nifedipine (DRUG).
Who is sponsoring clinical trial NCT06915792?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.